Skip to main content
. 2011 Feb 3;6(2):e16556. doi: 10.1371/journal.pone.0016556

Figure 7. Schematic model of BBR signaling pathway.

Figure 7

BBR inhibits mitochondria function and decrease intracellular ATP. This leads to a reduction in gluconeogenic and lipogenic transcription factors (FoxO1, SREBP1, and ChREBP). As a result, expression of gluconeogenic genes (PEPCK and G6Pase) and lipogenic gene (FAS) are decreased. These molecular changes represent a signaling pathway for improvement of fasting glucose and liver steatosis in the BBR-treated diabetic rats.

HHS Vulnerability Disclosure